Similarly, CDCA3 and HJURP displayed reproducible negative correlations with distinct NSC derivatives (e.g., NSC685416, NSC709900), consistent with enhanced drug sensitivity in tumours with elevated expression. The gene discussed is CDCA3; the disease is neoplasm.